News of the WeekLyme Disease

Patients Scarce in Test of Long-Term Therapy

See allHide authors and affiliations

Science  05 Mar 1999:
Vol. 283, Issue 5407, pp. 1431
DOI: 10.1126/science.283.5407.1431

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Scientists are having trouble meeting enrollment targets for a $4.2 million study of Chronic Lyme Disease intended to test whether a 90-day course of antibiotics makes patients feel better. Even as the scientists debate the proper treatment for the disease, officials in Connecticut, ground zero for the disease, are battling insurance companies on behalf of patients seeking reimbursement for extended Lyme disease therapy.